Weight-loss drug makers Novo Nordisk and Eli Lilly saw their stocks drop Friday after President Donald Trump vowed to lower the price of Novo's popular Ozempic treatment. At such a critical moment in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback